ArticleEuropean heart journal2018

CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.

Diogo Mosqueira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.